Vascular Biogenics (VBLT) News Today → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free VBLT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVascular Biogenics (VBLT) Price Target Increased by 160.00% to 13.26msn.com - November 3 at 12:39 AMNotable Labs Closes Merger Transaction With VBL Therapeuticsfinance.yahoo.com - October 16 at 3:55 PMVBL Therapeutics Announces Results of Annual and Special Shareholder Meetingfinance.yahoo.com - October 12 at 3:13 PMVBL Therapeutics Reminds Shareholders to Vote in the Upcoming Annual and Special Shareholder Meetingfinance.yahoo.com - October 4 at 8:40 AMVascular Biogenics Rises on Presentation Hypefinance.yahoo.com - September 9 at 12:00 PMVBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SECfinance.yahoo.com - September 6 at 7:30 PMVASCULAR BIOGENICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vascular Biogenics Ltd. - VBLTbusinesswire.com - August 28 at 7:00 PMVASCULAR BIOGENICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vascular Biogenics Ltd. - VBLTbusinesswire.com - August 28 at 3:04 PMVBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - August 14 at 8:09 AMVascular Biogenics (NASDAQ: VBLT)fool.com - July 23 at 5:52 PMVBL Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - May 15 at 8:03 PMVascular Biogenics Stock (NASDAQ:VBLT), Dividendsbenzinga.com - April 4 at 1:52 AMVascular Biogenics Full Year 2022 Earnings: US$0.42 loss per share (vs US$0.45 loss in FY 2021)finance.yahoo.com - March 17 at 8:38 AMVBL Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - March 14 at 9:17 AMVBL Therapeutics Announces Closing of Sale of Manufacturing Facility and Certain Related Assets for $7.1 Million in Cashfinance.yahoo.com - March 9 at 9:10 AMSHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Vascular Biogenics Ltd. - VBLTprnewswire.com - February 27 at 10:12 PMVBLT STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Vascular Biogenics Ltd. Is Fair to Shareholderstechnews.tmcnet.com - February 23 at 6:48 PMSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Vascular Biogenics Ltd. Mergerbenzinga.com - February 23 at 6:48 PMVascular Biogenics Shares Jump Premarket on Reverse Merger Plans >VBLTmarketwatch.com - February 23 at 6:48 PMVascular Biogenics rises 85% on all-stock merger deal with Notable Labsmsn.com - February 23 at 6:48 PMWhy Is Vascular Biogenics (VBLT) Stock Up 52%?investorplace.com - February 23 at 12:09 PMmarketbeat.com - February 23 at 6:57 AMVBL Therapeutics Announces Agreement to Sell Manufacturing Facility and Certain Related Assets for $7.1 Million in Cashfinance.yahoo.com - February 16 at 1:06 PMOYSTER PT PHARM (OYST) Reports Q3 Loss, Lags Revenue Estimatesfinance.yahoo.com - November 10 at 7:22 PMAxsome (AXSM) Starts Late-Stage Study of Migraine Drug AXS-07finance.yahoo.com - September 2 at 5:52 PMVBL Therapeutics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiencyfinance.yahoo.com - September 1 at 9:32 PMSorrento (SRNE) Gets FDA Fast Track Tag for Back Pain Productfinance.yahoo.com - September 1 at 4:32 PMVascular Biogenics Cutting About 35% of Staff >VBLTmarketwatch.com - August 2 at 1:24 PMVBL Therapeutics Announces Workforce Reductionfinance.yahoo.com - August 2 at 8:23 AMVascular Biogenics (VBLT) Down, Ovarian Cancer Study Failsfinance.yahoo.com - July 21 at 3:03 PMGold Prices Settle Lower; Vascular Biogenics Shares Plummetmsn.com - July 20 at 6:58 PMWhy Is Vascular Biogenics (VBLT) Stock Down 80% Today?msn.com - July 20 at 1:54 PMRead Why VBL Therapeutics Shares Are Falling To a 52-Week Lowfinance.yahoo.com - July 20 at 1:54 PMVBL Therapeutics Announces Top-Line Data from Phase 3 OVAL Trial of Ofra-Vec in Patients with Platinum-Resistant Ovarian Cancerfinance.yahoo.com - July 19 at 8:34 PMmarketbeat.com - July 19 at 4:04 PMVascular Biogenics (NASDAQ:VBLT) Given "Outperform" Rating at Oppenheimermarketbeat.com - July 18 at 10:44 AMShort Interest in Vascular Biogenics Ltd. (NASDAQ:VBLT) Declines By 22.4%marketbeat.com - July 4 at 2:28 AMVascular Biogenics (NASDAQ:VBLT) Upgraded by Zacks Investment Research to Holdmarketbeat.com - June 10 at 7:19 AMVBL Therapeutics to Participate in the Jefferies Healthcare Conferencefinance.yahoo.com - May 31 at 11:51 AMQ2 2022 EPS Estimates for Vascular Biogenics Ltd. (NASDAQ:VBLT) Decreased by Oppenheimermarketbeat.com - May 20 at 7:35 AMOppenheimer Comments on Vascular Biogenics Ltd.'s Q1 2023 Earnings (NASDAQ:VBLT)marketbeat.com - May 19 at 6:45 AMVBL Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updatestockhouse.com - May 17 at 11:47 AMVBL Therapeutics to Report First Quarter 2022 Financial Results on May 17finance.yahoo.com - May 10 at 10:41 AMWhat Kind Of Shareholders Hold The Majority In Vascular Biogenics Ltd.'s (NASDAQ:VBLT) Shares?finance.yahoo.com - May 8 at 2:40 PMVBL Therapeutics to Participate in Upcoming Scientific and Industry Conferences in Mayfinance.yahoo.com - May 3 at 10:13 AMVascular Biogenics (NASDAQ:VBLT) Now Covered by Analysts at Chardan Capitalmarketbeat.com - April 28 at 7:07 AMThe Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell ...msn.com - April 26 at 1:08 PMVascular Biogenics (VBLT) Presents at the KOL Event on Ovarian Cancer - Slideshowseekingalpha.com - April 16 at 11:40 PMZacks Investment Research Lowers Vascular Biogenics (NASDAQ:VBLT) to Sellmarketbeat.com - March 29 at 1:53 PMVBL Therapeutics Reports Full Year 2021 Financial Results and Provides Corporate Updatefinance.yahoo.com - March 23 at 9:21 AM Get Vascular Biogenics News Delivered to You Automatically Sign up to receive the latest news and ratings for VBLT and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him VBLT Media Mentions By Week VBLT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VBLT News Sentiment▼0.000.41▲Average Medical News Sentiment VBLT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VBLT Articles This Week▼00▲VBLT Articles Average Week Get Vascular Biogenics News Delivered to You Automatically Sign up to receive the latest news and ratings for VBLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TVTX News ANRO News ANNX News SLRN News TBPH News LRMR News NGNE News FULC News TRDA News PEPG News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VBLT) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vascular Biogenics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.